The neuropathogenesis of HIV-1 infection

Handbook of Clinical Neurology

Volumn 85, Issue , 2007, Pages 45-67

  Buescher, James L ^a   Gross, Sara ^a   Gendelman, Howard E ^a   Ikezu, Tsuneya ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649345655     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)85004-4     Document Type: Review

References (301)

1. Abraham C.S., Deli M.A., Joo F., et al. Intracarotid tumor necrosis factor-alpha administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis. Neurosci Lett 208 (1996) 85-88
2. Abraham K.E., McMillen D., and Brewer K.L. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse. Neuroscience 124 (2004) 945-952
3. Adamson D.C., Wildemann B., Sasaki M., et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274 (1996) 1917-1921
4. Adamson D.C., Kopnisky K.L., Dawson T.M., et al. Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity. J Neurosci 19 (1999) 64-71
5. Adle-Biassette H., Levy Y., Colombel M., et al. Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 21 (1995) 218-227
6. Adle-Biassette H., Chretien F., Wingertsmann L., et al. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 25 (1999) 123-133
7. Akira S., and Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127 (1992) 25-50
8. Albright A.V., Shieh J.T., Itoh T., et al. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 73 (1999) 205-213
9. An S.F., Giometto B., Scaravilli T., et al. Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients. Acta Neuropathol (Berl) 91 (1996) 169-173
10. An S.F., Groves M., Gray F., et al. Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol 58 (1999) 1156-1162
11. Anderson E., Zink W., Xiong H., et al. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr 31 Suppl 2 (2002) S43-S54
12. Anderson E., and Xiong H. Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. J Neurosci 24 (2004) 7194-7198
13. Avraham H.K., Jiang S., Lee T.H., et al. HIV-1 Tat-mediated effects on focal adhesion assembly and permeability in brain microvascular endothelial cells. J Immunol 173 (2004) 6228-6233
14. Bachis A., Major E.O., and Mocchetti I. Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization. J Neurosci 23 (2003) 5715-5722
15. Bagasra O., Lavi E., Bobroski L., et al. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10 (1996) 573-585
16. Ballabh P., Braun A., and Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16 (2004) 1-13
17. Banks W.A. The blood-brain barrier: its structure and function. In: Gendelman H., Everall I.P., Lipton S., and Swindells S. (Eds). The Neurology of AIDS (2005), Oxford University Press
18. Banks W.A., Akerstrom V., and Kastin A.J. Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization coreceptor. J Cell Sci 111 Pt 4 (1998) 533-540
19. Banks W.A., Freed E.O., Wolf K.M., et al. Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosis. J Virol 75 (2001) 4681-4691
20. Baptiste D.C., Hartwick A.T., Jollimore C.A., et al. An investigation of the neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death. Mol Pharmacol 66 (2004) 1113-1122
21. Barks J.D., Liu X.H., Sun R., et al. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience 76 (1997) 397-409
22. Batchelor P.E., Liberatore G.T., Wong J.Y., et al. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19 (1999) 1708-1716
23. Batrakova E.V., Li S., Vinogradov S.V., et al. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther 299 (2001) 483-493
24. Batrakova E.V., Miller D.W., Li S., et al. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J Pharmacol Exp Ther 296 (2001) 551-557
25. Batrakova E.V., Li S., Alakhov V.Y., et al. Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. Pharm Res 20 (2003) 1581-1590
26. Beer R., Franz G., Schopf M., et al. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab 20 (2000) 669-677
27. Bell M.D., Taub D.D., and Perry V.H. Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience 74 (1996) 283-292
28. Beltrami E.M., Williams I.T., Shapiro C.N., et al. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev 13 (2000) 385-407
29. Bennett B.A., Rusyniak D.E., and Hollingsworth C.K. HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. Brain Res 705 (1995) 168-176
30. Bevilacqua M.P., Stengelin S., Gimbrone Jr. M.A., et al. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243 (1989) 1160-1165
31. Bezzi P., Carmignoto G., Pasti L., et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391 (1998) 281-285
32. Bi H., and Sze C.I. N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. J Neurol Sci 200 (2002) 11-18
33. Bormann J. Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 166 (1989) 591-592
34. Boska M.D., Mosley R.L., Nawab M., et al. Advances in neuroimaging for HIV-1 associated neurological dysfunction: clues to the diagnosis, pathogenesis and therapeutic monitoring. Curr HIV Res 2 (2004) 61-78
35. Boutet A., Salim H., Leclerc P., et al. Cellular expression of functional chemokine receptor CCR5 and CXCR4 in human embryonic neurons. Neurosci Lett 311 (2001) 105-108
36. Boven L.A., Gomes L., Hery C., et al. Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol 162 (1999) 4319-4327
37. Boven L.A., Middel J., Breij E.C., et al. Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines. J Neurovirol 6 (2000) 382-389
38. Brew B.J., and Miller J. Human immunodeficiency virus type 1-related transient neurological deficits. Am J Med 101 (1996) 257-261
39. Brew B.J., Bhalla R.B., Paul M., et al. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol 28 (1990) 556-560
40. Brew B.J., Dunbar N., Pemberton L., et al. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. J Infect Dis 174 (1996) 294-298
41. Brew B.J., Evans L., Byrne C., et al. The relationship between AIDS dementia complex and the presence of macrophage tropic and non-syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid. J Neurovirol 2 (1996) 152-157
42. Brew B.J., Wesselingh S.L., Gonzales M., et al. Managing HIV: 3. Mechanisms of diseases. 3.7 How HIV leads to neurological disease. Med J Aust 164 (1996) 233-234
43. Brouwers P., Heyes M.P., Moss H.A., et al. Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J Infect Dis 168 (1993) 1380-1386
44. Bukrinsky M.I., Nottet H.S., Schmidtmayerova H., et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 181 (1995) 735-745
45. Burkala E., West J.T., Jun H., et al. The choroid plexus and viral entry into the brain. In: Gendelman H.E., Everall I.P., Lipton S.A., and Swindells S. (Eds). The Neurology of AIDS (2004), Oxford University Press
46. Calvo Manuel E., Arranz Garcia F., Sanchez-Portocarrero J., et al. [Alpha tumor necrosis factor in central nervous system disease associated with HIV infection]. An Med Interna 12 (1995) 263-266
47. Carlos T., Kovach N., Schwartz B., et al. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 77 (1991) 2266-2271
48. Carlson K., Leisman G., Limoges J., et al. Molecular characterization of a putative anti-retroviral transcriptional factor, OTK18. J Immunol 172 (2004) 381-391
49. Carlson K.A., Limoges J., Pohlman G.D., et al. OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis. J Neuroimmunol 150 (2004) 186-198
50. Carpenter C.C., Cooper D.A., Fischl M.A., et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 283 (2000) 381-390
51. Carson M.J., and Sutcliffe J.G. Balancing function vs. self defense: the CNS as an active regulator of immune responses. J Neurosci Res 55 (1999) 1-8
52. Cavender D.E., Edelbaum D., and Ziff M. Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol 134 (1989) 551-560
53. Chang L., Ernst T., Leonido-Yee M., et al. Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex. Neurology 54 (2000) 389-396
54. Chang L., Speck O., Miller E.N., et al. Neural correlates of attention and working memory deficits in HIV patients. Neurology 57 (2001) 1001-1007
55. Chao C.C., Hu S., Sheng W.S., et al. Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines. Dev Neurosci 17 (1995) 97-105
56. Chauhan N.B., Siegel G.J., and Lee J.M. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain. J Chem Neuroanat 21 (2001) 277-288
57. Chen G., Zeng W.Z., Yuan P.X., et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72 (1999) 879-882
58. Cheng J., Nath A., Knudsen B., et al. Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein. Neuroscience 82 (1998) 97-106
59. Cho C., and Miller R.J. Chemokine receptors and neural function. J Neurovirol 8 (2002) 573-584
60. Choi C., Park J.Y., Lee J., et al. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol 162 (1999) 1889-1895
61. Choo E.F., Leake B., Wandel C., et al. Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos 28 (2000) 655-660
62. Cicala C., Arthos J., Selig S.M., et al. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci USA 99 (2002) 9380-9385
63. Clifford D.B. Human immunodeficiency virus-associated dementia. Arch Neurol 57 (2000) 321-324
64. Conant K., Garzino-Demo A., Nath A., et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 95 (1998) 3117-3121
65. Connor B., and Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 27 (1998) 1-39
66. Corasaniti M.T., Bilotta A., Strongoli M.C., et al. HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death. Br J Pharmacol 134 (2001) 1344-1350
67. Corasaniti M.T., Piccirilli S., Paoletti A., et al. Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor. Neurosci Lett 312 (2001) 67-70
68. Cordon-Cardo C., O'Brien J.P., Casals D., et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86 (1989) 695-698
69. Corosaniti M. Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 (COX-2) and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-72389G. Biochem Biophys Res Commun 274 (2000) 664-669
70. Cunningham P.H., Smith D.G., Satchell C., et al. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS 14 (2000) 1949-1954
71. d'Arminio Monforte A., Duca P.G., Vago L., et al. Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology 54 (2000) 1856-1859
72. Davis L.E., Hjelle B.L., Miller V.E., et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42 (1992) 1736-1739
73. Dawson V.L., Dawson T.M., Uhl G.R., et al. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 90 (1993) 3256-3259
74. Di Stefano M. HIV-1 structural and regulatory proteins and neurotoxicity. In: Gendelman H.E., Grant I., Everall I.P., Lipton S.A., and Swindells S. (Eds). The Neurology of AIDS (2004), Oxford University Press
75. Dickson D.W., Mattiace L.A., Kure K., et al. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 64 (1991) 135-156
76. Dietrich W.D., Busto R., and Bethea J.R. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp Neurol 158 (1999) 444-450
77. Diop A.G., Lesort M., Esclaire F., et al. Calbindin D28K-containing neurons, and not HSP70-expressing neurons, are more resistant to HIV-1 envelope (gp120) toxicity in cortical cell cultures. J Neurosci Res 42 (1995) 252-258
78. Dore G.J., Hoy J.F., Mallal S.A., et al. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort. J Acquir Immune Defic Syndr Hum Retrovirol 16 (1997) 39-43
79. Dore G.J., Correll P.K., Li Y., et al. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13 (1999) 1249-1253
80. Dou H., Birusingh K., Faraci J., et al. Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J Neurosci 23 (2003) 9162-9170
81. Dou H., Kingsley J.D., Mosley R.L., et al. Neuroprotective strategies for HIV-1 associated dementia. Neurotox Res 6 (2004) 503-521
82. Douek D.C., McFarland R.D., Keiser P.H., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 (1998) 690-695
83. Dreyer E.B., Kaiser P.K., Offermann J.T., et al. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248 (1990) 364-367
84. Elkabes S., DiCicco-Bloom E.M., and Black I.B. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci 16 (1996) 2508-2521
85. Ellis R.J., Deutsch R., Heaton R.K., et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 54 (1997) 416-424
86. Ellis R.J., Moore D.J., Childers M.E., et al. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 59 (2002) 923-928
87. Enting R.H., Hoetelmans R.M., Lange J.M., et al. Antiretroviral drugs and the central nervous system. AIDS 12 (1998) 1941-1955
88. Ernst T., Chang L., Jovicich J., et al. Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 59 (2002) 1343-1349
89. Eugenin E.A., and Berman J.W. Mechanisms of viral entry through the blood-brain barrier. In: Gendelman H., Epstein L., and Swidells S. (Eds). The Neurology of AIDS (2005), Oxford University Press
90. Everall I.P., Trillo-Pazos G., Bell C., et al. Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection. J Neuropathol Exp Neurol 60 (2001) 293-301
91. Everall I.P., Bell C., Mallory M., et al. Lithium ameliorates HIV-gp120-mediated neurotoxicity. Mol Cell Neurosci 21 (2002) 493-501
92. Felderhoff-Mueser U., Sifringer M., Pesditschek S., et al. Pathways leading to apoptotic neurodegeneration following trauma to the developing rat brain. Neurobiol Dis 11 (2002) 231-245
93. Ferrando S., van Gorp W., McElhiney M., et al. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 12 (1998) F65-F70
94. Fiedorowicz A., Figiel I., Kaminska B., et al. Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure. Brain Res 912 (2001) 116-127
95. Fine S.M., Angel R.A., Perry S.W., et al. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem 271 (1996) 15303-15306
96. Finklestein S.P. The potential use of neurotrophic growth factors in the treatment of cerebral ischemia. Adv Neurol 71 (1996) 413-417 discussion 417-418
97. Fuchs D., Chiodi F., Albert J., et al. Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. AIDS 3 (1989) 285-288
98. Gabuzda D.H., Ho D.D., de la Monte S.M., et al. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 20 (1986) 289-295
99. Ganat Y., Soni S., Chacon M., et al. Chronic hypoxia up-regulates fibroblast growth factor ligands in the perinatal brain and induces fibroblast growth factor-responsive radial glial cells in the sub-ependymal zone. Neuroscience 112 (2002) 977-991
100. Garaci E., Caroleo M.C., Aloe L., et al. Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc Natl Acad Sci USA 96 (1999) 14013-14018
101. Gardner J., and Ghorpade A. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res 74 (2003) 801-806
102. Gartner S. HIV infection and dementia. Science 287 (2000) 602-604
103. Geissler R.G., Ottmann O.G., Eder M., et al. Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of HIV-infected persons. Ann Hematol 62 (1991) 151-155
104. Gelbard H.A., Nottet H.S., Swindells S., et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 68 (1994) 4628-4635
105. Gendelman H.E., and Meltzer M.S. Mononuclear phagocytes and the human immunodeficiency virus. Curr Opin Immunol 2 (1989) 414-419
106. Gendelman H.E., Narayan O., Kennedy-Stoskopf S., et al. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol 58 (1986) 67-74
107. Gendelman H.E., Zheng J., Coulter C.L., et al. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J Infect Dis 178 (1998) 1000-1007
108. Gendelman H.E., Diesing S., Gelbard H., et al. The neuropathogenesis of HIV-1 infection. In: Wormser G.P. (Ed). AIDS and Other Manifestations of HIV Infection (2004), Elsevier Press
109. Genis P., Jett M., Bernton E.W., et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176 (1992) 1703-1718
110. Ghorpade A., Nukuna A., Che M., et al. Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J Virol 72 (1998) 3340-3350
111. Ghorpade A., Holter S., Borgmann K., et al. HIV-1 and IL-1 beta regulate Fas ligand expression in human astrocytes through the NF-kappa B pathway. J Neuroimmunol 141 (2003) 141-149
112. Goudsmit J., de Wolf F., Paul D.A., et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 2 (1986) 177-180
113. Gras G., Chretien F., Vallat-Decouvelaere A.V., et al. Regulated expression of sodium-dependent glutamate transporters and synthetase: a neuroprotective role for activated microglia and macrophages in HIV infection?. Brain Pathol 13 (2003) 211-222
114. Gray F., Adle-Biassette H., Brion F., et al. Neuronal apoptosis in human immunodeficiency virus infection. J Neurovirol 6 Suppl 1 (2000) S38-S43
115. Green D.R. The suicide in the thymus, a twisted trail. Nat Immunol 4 (2003) 207-208
116. Griffin G.E., Leung K., Folks T.M., et al. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature 339 (1989) 70-73
117. Groothuis D.R., and Levy R.M. The entry of antiviral and antiretroviral drugs into the central nervous system. J Neurovirol 3 (1997) 387-400
118. Haase A.T. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol 17 (1999) 625-656
119. Hayashi M., Ueyama T., Nemoto K., et al. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 17 (2000) 203-218
120. Hayes M.M., Lane B.R., King S.R., et al. Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. J Biol Chem 277 (2002) 16913-16919
121. Heidenreich F., Arendt G., Jander S., et al. Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases. J Neuroimmunol 52 (1994) 117-126
122. Henderson A.J., Zou X., and Calame K.L. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 69 (1995) 5337-5344
123. Henderson A.J., Connor R.I., and Calame K.L. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5 (1996) 91-101
124. Hession C., Osborn L., Goff D., et al. Endothelial leukocyte adhesion molecule 1: direct expression cloning and functional interactions. Proc Natl Acad Sci USA 87 (1990) 1673-1677
125. Heyes M.P., Brew B.J., Martin A., et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 29 (1991) 202-209
126. Heyes M.P., Ellis R.J., Ryan L., et al. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain 124 (2001) 1033-1042
127. Ho D.D., Rota T.R., Schooley R.T., et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 313 (1985) 1493-1497
128. Ho D.D., Neumann A.U., Perelson A.S., et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (1995) 123-126
129. Hongisto V., Smeds N., Brecht S., et al. Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3. Mol Cell Biol 23 (2003) 6027-6036
130. Hori K., Burd P.R., Furuke K., et al. Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. Blood 93 (1999) 1843-1850
131. Huang M.B., and Bond V.C. Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium. J Acquir Immune Defic Syndr 25 (2000) 375-389
132. Huang M.B., Jin L.L., James C.O., et al. Characterization of Nef-CXCR4 interactions important for apoptosis induction. J Virol 78 (2004) 11084-11096
133. Hurwitz A.A., Lyman W.D., Guida M.P., et al. Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes. J Exp Med 176 (1992) 1631-1636
134. Isalan M., Klug A., and Choo Y. A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat Biotechnol 19 (2001) 656-660
135. Iskander S., Walsh K.A., and Hammond R.R. Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia. J Neuroinflammation 1 (2004) 7
136. Jain K.K. Evaluation of memantine for neuroprotection in dementia. Expert Opin Investig Drugs 9 (2000) 1397-1406
137. James C.O., Huang M.B., Khan M., et al. Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J Virol 78 (2004) 3099-3109
138. 2-) regulatory pathways. J Immunol 157 (1996) 2129-2135
139. Janabi N., Di Stefano M., Wallon C., et al. Induction of human immunodeficiency virus type 1 replication in human glial cells after proinflammatory cytokines stimulation: effect of IFNgamma, IL1beta, and TNFalpha on differentiation and chemokine production in glial cells. Glia 23 (1998) 304-315
140. Janssen R.S., Saykin A.J., Cannon L., et al. Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection. Ann Neurol 26 (1989) 592-600
141. Janzer R.C., and Raff M.C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325 (1987) 253-257
142. Jassoy C., Harrer T., Rosenthal T., et al. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens. J Virol 67 (1993) 2844-2852
143. Jiang X., Zhu D., Okagaki P., et al. N-methyl-D-aspartate and TrkB receptor activation in cerebellar granule cells: an in vitro model of preconditioning to stimulate intrinsic survival pathways in neurons. Ann N Y Acad Sci 993 (2003) 134-145 discussion 159-160
144. Jiang Z.G., Piggee C., Heyes M.P., et al. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J Neuroimmunol 117 (2001) 97-107
145. Johnson V.J., and Sharma R.P. Aluminum disrupts the pro-inflammatory cytokine/neurotrophin balance in primary brain rotation-mediated aggregate cultures: possible role in neurodegeneration. Neurotoxicology 24 (2003) 261-268
146. Kaiser P.K., Offermann J.T., and Lipton S.A. Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. Neurology 40 (1990) 1757-1761
147. Kaul M., Garden G.A., and Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410 (2001) 988-994
148. Kawahara M., Sakata A., Miyashita T., et al. Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice. J Pharm Sci 88 (1999) 1281-1287
149. Kelly A., Vereker E., Nolan Y., et al. Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1 beta on long term potentiation in rat dentate gyrus. J Biol Chem 278 (2003) 19453-19462
150. Kerr S.J., Armati P.J., Pemberton L.A., et al. Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages. Neurology 49 (1997) 1671-1681
151. Kestler III H.W., Ringler D.J., Mori K., et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65 (1991) 651-662
152. Kim J.S., Gautam S.C., Chopp M., et al. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neuroimmunol 56 (1995) 127-134
153. Kim R.B., Fromm M.F., Wandel C., et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 101 (1998) 289-294
154. Koeberle P.D., Gauldie J., and Ball A.K. Effects of adenoviral-mediated gene transfer of interleukin-10, interleukin-4, and transforming growth factor-beta on the survival of axotomized retinal ganglion cells. Neuroscience 125 (2004) 903-920
155. Koedel U., Kohleisen B., Sporer B., et al. HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system. J Immunol 163 (1999) 1237-1245
156. Koenig S., Gendelman H.E., Orenstein J.M., et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233 (1986) 1089-1093
157. Koka P., He K., Zack J.A., et al. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 182 (1995) 941-951
158. Koup R.A., Safrit J.T., Cao Y., et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68 (1994) 4650-4655
159. Krebs F.C., Ross H., McAllister J., et al. HIV-1-associated central nervous system dysfunction. Adv Pharmacol 49 (2000) 315-385
160. Krishnakumar D., Lal R.B., and Dhawan S. Immunology of HIV-1. In: Gendelman H.E., Grant I., Everall I.P., Lipton S.A., and Swindells S. (Eds). The Neurology of AIDS (2005), Oxford University Press
161. Kullander K., Kylberg A., and Ebendal T. Specificity of neurotrophin-3 determined by loss-of-function mutagenesis. J Neurosci Res 50 (1997) 496-503
162. Kure K., Lyman W.D., Weidenheim K.M., et al. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol 136 (1990) 1085-1092
163. Kutsch O., Oh J., Nath A., et al. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol 74 (2000) 9214-9221
164. Lackritz E.M. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. AIDS 12 Suppl A (1998) S81-S86
165. Lavi E., Strizki J.M., Ulrich A.M., et al. CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol 151 (1997) 1035-1042
166. Lazarov-Spiegler O., Solomon A.S., Zeev-Brann A.B., et al. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J 10 (1996) 1296-1302
167. Lee C.G., Gottesman M.M., Cardarelli C.O., et al. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 37 (1998) 3594-3601
168. Lee C.W., Lau K.F., Miller C.C., et al. Glycogen synthase kinase-3 beta-mediated tau phosphorylation in cultured cell lines. Neuroreport 14 (2003) 257-260
169. Leppert D., Waubant E., Galardy R., et al. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154 (1995) 4379-4389
170. Letendre S.L., McCutchan J.A., Childers M.E., et al. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 56 (2004) 416-423
171. Linseman D.A., Cornejo B.J., Le S.S., et al. A myocyte enhancer factor 2D (MEF2D) kinase activated during neuronal apoptosis is a novel target inhibited by lithium. J Neurochem 85 (2003) 1488-1499
172. Lipsky R.H., Xu K., Zhu D., et al. Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection. J Neurochem 78 (2001) 254-264
173. Lipton S.A. Treating AIDS dementia. Science 276 (1997) 1629-1630
174. Lipton S.A., and Gendelman H.E. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332 (1995) 934-940
175. Liu N.Q., Lossinsky A.S., Popik W., et al. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol 76 (2002) 6689-6700
176. Liu R., Paxton W.A., Choe S., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 (1996) 367-377
177. Liu X., Jana M., Dasgupta S., et al. Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia. J Biol Chem 277 (2002) 39312-39319
178. Liu Y., Jones M., Hingtgen C.M., et al. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 6 (2000) 1380-1387
179. Lu L., Leonessa F., Clarke R., et al. Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase. Mol Pharmacol 59 (2001) 62-68
180. Luo X., Carlson K.A., Wojna V., et al. Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 60 (2003) 1931-1937
181. Macdonald N.J., Perez-Polo J.R., Bennett A.D., et al. NGF-resistant PC12 cell death induced by arachidonic acid is accompanied by a decrease of active PKC zeta and nuclear factor kappa B. J Neurosci Res 57 (1999) 219-226
182. Maciejewski J.P., Weichold F.F., and Young N.S. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J Immunol 153 (1994) 4303-4310
183. Maggirwar S.B., Tong N., Ramirez S., et al. HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem 73 (1999) 578-586
184. Major E.O., Rausch D., Marra C., et al. HIV-associated dementia. Science 288 (2000) 440-442
185. Marechal V., Prevost M.C., Petit C., et al. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J Virol 75 (2001) 11166-11177
186. Marmigere F., Rage F., and Tapia-Arancibia L. GABA-glutamate interaction in the control of BDNF expression in hypothalamic neurons. Neurochem Int 42 (2003) 353-358
187. Martin C., Berridge G., Higgins C.F., et al. Communication between multiple drug binding sites on P-glycoprotein. Mol Pharmacol 58 (2000) 624-632
188. Masliah E., Ge N., Achim C.L., et al. Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis. J Neuropathol Exp Neurol 54 (1995) 350-357
189. McArthur J.C. HIV dementia: an evolving disease. J Neuroimmunol 157 (2004) 3-10
190. McArthur J.C., Nance-Sproson T.E., Griffin D.E., et al. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. Neurology 42 (1992) 1707-1712
191. McArthur J.C., Sacktor N., and Selnes O. Human immunodeficiency virus-associated dementia. Semin Neurol 19 (1999) 129-150
192. McArthur J.C., Haughey N., Gartner S., et al. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 9 (2003) 205-221
193. McManus C.M., Weidenheim K., Woodman S.E., et al. Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol 156 (2000) 1441-1453
194. Medana I.M., Gallimore A., Oxenius A., et al. MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur J Immunol 30 (2000) 3623-3633
195. Merrill J.E., Koyanagi Y., Zack J., et al. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 66 (1992) 2217-2225
196. Messam C.A., and Major E.O. Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. J Neurovirol 6 Suppl 1 (2000) S90-S94
197. Meucci O., and Miller R.J. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J Neurosci 16 (1996) 4080-4088
198. Milligan C.E., Cunningham T.J., and Levitt P. Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain. J Comp Neurol 314 (1991) 125-135
199. Miwa T., Furukawa S., Nakajima K., et al. Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J Neurosci Res 50 (1997) 1023-1029
200. Mordelet E., Kissa K., Cressant A., et al. Histopathological and cognitive defects induced by Nef in the brain. Faseb J 18 (2004) 1851-1861
201. Muthumani K., Choo A.Y., Hwang D.S., et al. Mechanism of HIV-1 viral protein R-induced apoptosis. Biochem Biophys Res Commun 304 (2003) 583-592
202. Namiki J., Kojima A., and Tator C.H. Effect of brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 on functional recovery and regeneration after spinal cord injury in adult rats. J Neurotrauma 17 (2000) 1219-1231
203. Nath A., Haughey N.J., Jones M., et al. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47 (2000) 186-194
204. Navia B.A., Jordan B.D., and Price R.W. The AIDS dementia complex: I. Clinical features. Ann Neurol 19 (1986) 517-524
205. Newell M.L. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS 12 (1998) 831-837
206. Newton P.J., Newsholme W., Brink N.S., et al. Acute meningoencephalitis and meningitis due to primary HIV infection. BMJ 325 (2002) 1225-1227
207. Nottet H.S. The blood-brain barrier: monocyte and viral entry into the brain. In: Gendelman H.E., Grant I., Everall I.P., Lipton S.A., and Swindells S. (Eds). The Neurology of AIDS (2004), Oxford University Press
208. Nottet H., and Dhawan S. HIV-1 entry into the brain: mechanisms for the infiltration of HIV-1 infected macrophages across blood-brain barrier. In: Gendelman H., Epstein L., and Swidells S. (Eds). The Neurology of AIDS (1997), Chapman & Hall, New York
209. Nottet H.S., Jett M., Flanagan C.R., et al. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol 154 (1995) 3567-3581
210. Nottet H.S., Persidsky Y., Sasseville V.G., et al. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 156 (1996) 1284-1295
211. Orenstein J.M., Meltzer M.S., Phipps T., et al. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J Virol 62 (1988) 2578-2586
212. Osborn L., Hession C., Tizard R., et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59 (1989) 1203-1211
213. Pardridge W.M. Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev 63 (1983) 1481-1535
214. Patarca R., Freeman G.J., Schwartz J., et al. rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1. Proc Natl Acad Sci USA 85 (1988) 2733-2737
215. Patton H.K., Zhou Z.H., Bubien J.K., et al. gp120-induced alterations of human astrocyte function: Na(+)/H(+) exchange, K(+) conductance, and glutamate flux. Am J Physiol Cell Physiol 279 (2000) C700-C708
216. Paula-Barbosa M.M., Pereira P.A., Cadete-Leite A., et al. NGF and NT-3 exert differential effects on the expression of neuropeptides in the suprachiasmatic nucleus of rats withdrawn from ethanol treatment. Brain Res 983 (2003) 64-73
217. Pavlakis S.G., Lu D., Frank Y., et al. Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy. AJNR Am J Neuroradiol 19 (1998) 383-385
218. Peluso R., Haase A., Stowring L., et al. A Trojan horse mechanism for the spread of visna virus in monocytes. Virology 147 (1985) 231-236
219. Pemberton L.A., and Brew B.J. Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex. J Clin Virol 22 (2001) 249-253
220. Persidsky Y., and Gendelman H.E. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J Leukoc Biol 74 (2003) 691-701
221. Persidsky Y., Stins M., Way D., et al. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 158 (1997) 3499-3510
222. Persidsky Y., Zheng J., Miller D., et al. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68 (2000) 413-422
223. Petito C.K., and Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 146 (1995) 1121-1130
224. Piller S.C., Jans P., Gage P.W., et al. Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc Natl Acad Sci USA 95 (1998) 4595-4600
225. Pomerantz R.J. Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis. DNA Cell Biol 23 (2004) 227-238
226. Pulliam L., Gascon R., Stubblebine M., et al. Unique monocyte subset in patients with AIDS dementia. Lancet 349 (1997) 692-695
227. Pulliam L., Zhou M., Stubblebine M., et al. Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor. J Neurosci Res 54 (1998) 530-538
228. Ramirez S.H., Sanchez J.F., Dimitri C.A., et al. Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappaB (NF-kappaB)-dependent mechanism. J Neurochem 78 (2001) 874-889
229. Rapalino O., Lazarov-Spiegler O., Agranov E., et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 4 (1998) 814-821
230. Rappaport A., Shaked M., Landau M., et al. Sweet's syndrome in association with Crohn's disease: report of a case and review of the literature. Dis Colon Rectum 44 (2001) 1526-1529
231. Ray R.B., and Srinivas R.V. Inhibition of human immunodeficiency virus type 1 replication by a cellular transcriptional factor MBP-1. J Cell Biochem 64 (1997) 565-572
232. Reynolds L., Ullman C., Moore M., et al. Repression of the HIV-1 5′ LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. Proc Natl Acad Sci USA 100 (2003) 1615-1620
233. Risau W., and Wolburg H. Development of the blood-brain barrier. Trends Neurosci 13 (1990) 174-178
234. Rocha M., Martins R.A., and Linden R. Activation of NMDA receptors protects against glutamate neurotoxicity in the retina: evidence for the involvement of neurotrophins. Brain Res 827 (1999) 79-92
235. Royal III W., Selnes O.A., Concha M., et al. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia. Ann Neurol 36 (1994) 32-39
236. Royce R.A., Sena A., Cates Jr. W., et al. Sexual transmission of HIV. N Engl J Med 336 (1997) 1072-1078
237. Rubin L.L., and Staddon J.M. The cell biology of the blood-brain barrier. Annu Rev Neurosci 22 (1999) 11-28
238. Ryan L.A., Peng H., Erichsen D.A., et al. TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia. J Neuroimmunol 148 (2004) 127-139
239. Sabri F., Tresoldi E., Di Stefano M., et al. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology 264 (1999) 370-384
240. Sabri F., De Milito A., Pirskanen R., et al. Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex. J Neuroimmunol 114 (2001) 197-206
241. Sacktor N.C., Bacellar H., Hoover D.R., et al. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol 2 (1996) 404-410
242. Sacktor N., Lyles R.H., Skolasky R., et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56 (2001) 257-260
243. Sacktor N., McDermott M.P., Marder K., et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8 (2002) 136-142
244. Saito H., Fujiwara T., Takahashi E.I., et al. Isolation and mapping of a novel human gene encoding a protein containing zinc-finger structures. Genomics 31 (1996) 376-379
245. Sasseville V.G., Newman W.A., Lackner A.A., et al. Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am J Pathol 141 (1992) 1021-1030
246. Schaffer B., Wiedau-Pazos M., and Geschwind D.H. Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3beta) in neural and non-neural tissues. Gene 302 (2003) 73-81
247. Schinkel A.H., Smit J.J., van T.O., et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77 (1994) 491-502
248. Schweighardt B., Shieh J.T., and Atwood W.J. CD4/CXCR4-independent infection of human astrocytes by a T-tropic strain of HIV-1. J Neurovirol 7 (2001) 155-162
249. Shi B., Raina J., Lorenzo A., et al. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J Neurovirol 4 (1998) 281-290
250. Shieh J.T., Albright A.V., Sharron M., et al. Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J Virol 72 (1998) 4243-4249
251. Sholl-Franco A., Marques P.M., Ferreira C.M., et al. IL-4 increases GABAergic phenotype in rat retinal cell cultures: involvement of muscarinic receptors and protein kinase C. J Neuroimmunol 133 (2002) 20-29
252. Shrikant P., Benos D.J., Tang L.P., et al. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J Immunol 156 (1996) 1307-1314
253. Smith G.M., and Hale J.H. Macrophage/microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-beta and basic fibroblast growth factor. J Neurosci 17 (1997) 9624-9633
254. Speliotes E.K., Caday C.G., Do T., et al. Increased expression of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Brain Res Mol Brain Res 39 (1996) 31-42
255. Spera P.A., Ellison J.A., Feuerstein G.Z., et al. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 251 (1998) 189-192
256. Speth C., Joebstl B., Barcova M., et al. HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones. AIDS 14 (2000) 629-636
257. Sporer B., Koedel U., Paul R., et al. Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J Neuroimmunol 102 (2000) 125-130
258. Stalder A.K., Carson M.J., Pagenstecher A., et al. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am J Pathol 153 (1998) 767-783
259. Stankoff B., Calvez V., Suarez S., et al. Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment. Eur J Neurol 6 (1999) 669-675
260. Staunton D.E., Marlin S.D., Stratowa C., et al. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52 (1988) 925-933
261. Strizki J.M., Albright A.V., Sheng H., et al. Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism. J Virol 70 (1996) 7654-7662
262. Stuart R.O., and Nigam S.K. Regulated assembly of tight junctions by protein kinase C. Proc Natl Acad Sci USA 92 (1995) 6072-6076
263. Subler M.A., Martin D.W., and Deb S. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53. J Virol 68 (1994) 103-110
264. Sugawara I., Hamada H., Tsuruo T., et al. Specialized localization of P-glycoprotein recognized by MRK 16 monoclonal antibody in endothelial cells of the brain and the spinal cord. Jpn J Cancer Res 81 (1990) 727-730
265. Suwanwelaa N., Phanuphak P., Phanthumchinda K., et al. Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. Magn Reson Imaging 18 (2000) 859-865
266. Syndulko K., Singer E.J., Nogales-Gaete J., et al. Laboratory evaluations in HIV-1-associated cognitive/motor complex. Psychiatr Clin North Am 17 (1994) 91-123
267. Takeshima H., Kuratsu J., Takeya M., et al. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg 80 (1994) 1056-1062
268. Talley A.K., Dewhurst S., Perry S.W., et al. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol Cell Biol 15 (1995) 2359-2366
269. Tardieu M. Mechanisms of macrophage-mediated neurotoxicity. In: Gendelman H.E., Grant I., Everall I.P., Lipton S.A., and Swindells S. (Eds). The Neurology of AIDS (2004), Oxford University Press
270. Tardieu M., and Boutet A. HIV-1 and the central nervous system. Curr Top Microbiol Immunol 265 (2002) 183-195
271. Tariot P.N., Farlow M.R., Grossberg G.T., et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291 (2004) 317-324
272. Tesmer V.M., Rajadhyaksha A., Babin J., et al. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90 (1993) 7298-7302
273. Titanji K., Nilsson A., Morch C., et al. Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection. Clin Exp Immunol 132 (2003) 297-303
274. Toggas S.M., Masliah E., Rockenstein E.M., et al. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367 (1994) 188-193
275. Tong N., Sanchez J.F., Maggirwar S.B., et al. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur J Neurosci 13 (2001) 1913-1922
276. Trillo-Pazos G., McFarlane-Abdulla E., Campbell I.C., et al. Recombinant nef HIV-IIIB protein is toxic to human neurons in culture. Brain Res 864 (2000) 315-326
277. Vallat A.V., De Girolami U., He J., et al. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 152 (1998) 167-178
278. Venne A., Li S., Mandeville R., et al. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res 56 (1996) 3626-3629
279. Vereker E., O'Donnell E., Lynch A., et al. Evidence that interleukin-1beta and reactive oxygen species production play a pivotal role in stress-induced impairment of LTP in the rat dentate gyrus. Eur J Neurosci 14 (2001) 1809-1819
280. Vitkovic L., Maeda S., and Sternberg E. Anti-inflammatory cytokines: expression and action in the brain. Neuroimmunomodulation 9 (2001) 295-312
281. von Giesen H.J., Wittsack H.J., Wenserski F., et al. Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1. Arch Neurol 58 (2001) 1281-1286
282. Wang Z., Pekarskaya O., Bencheikh M., et al. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 312 (2003) 60-73
283. Wei X., Ghosh S.K., Taylor M.E., et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373 (1995) 117-122
284. Weiden M., Tanaka N., Qiao Y., et al. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression. J Immunol 165 (2000) 2028-2039
285. Wesselingh S.L., Power C., Glass J.D., et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 33 (1993) 576-582
286. Wiley C.A. Pathology of neurologic disease in AIDS. Psychiatr Clin North Am 17 (1994) 1-15
287. Wilkinson I.D., Lunn S., Miszkiel K.A., et al. Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS. J Neurol Neurosurg Psychiatry 63 (1997) 477-482
288. Williams K.C., and Hickey W.F. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 25 (2002) 537-562
289. Williams K.C., Corey S., Westmoreland S.V., et al. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193 (2001) 905-915
290. Winkler C., Modi W., Smith M.W., et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279 (1998) 389-393
291. Wu H., Yang W.P., and Barbas III C.F. Building zinc fingers by selection: toward a therapeutic application. Proc Natl Acad Sci USA 92 (1995) 344-348
292. Wyss-Coray T., Masliah E., Toggas S.M., et al. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J Clin Invest 97 (1996) 789-798
293. Xiong H., Zeng Y.C., Zheng J., et al. Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia. J Neurovirol 5 (1999) 519-528
294. Xiong H., Zheng J., Thylin M., et al. Unraveling the mechanisms of neurotoxicity in HIV type 1-associated dementia: inhibition of neuronal synaptic transmission by macrophage secretory products. AIDS Res Hum Retroviruses 15 (1999) 57-63
295. Xiong H., Zeng Y.C., Lewis T., et al. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. J Neurovirol 6 Suppl 1 (2000) S14-S23
296. Xiong H., Boyle J., Winkelbauer M., et al. Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia. J Neurosci Res 71 (2003) 600-607
297. Xiong H., McCabe L., Skifter D., et al. Activation of NR1a/NR2B receptors by monocyte-derived macrophage secretory products: implications for human immunodeficiency virus type one-associated dementia. Neurosci Lett 341 (2003) 246-250
298. Yang Q.E. Eradication of HIV in infected patients: some potential approaches. Med Sci Monit 10 (2004) RA155-RA165
299. Yao H.B., Shaw P.C., Wong C.C., et al. Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain. J Chem Neuroanat 23 (2002) 291-297
300. Zhang Y., Han H., Elmquist W.F., et al. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res 876 (2000) 148-153
301. Zheng J., Thylin M.R., Ghorpade A., et al. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol 98 (1999) 185-200